A detailed history of Azzad Asset Management Inc /Adv transactions in Dexcom Inc stock. As of the latest transaction made, Azzad Asset Management Inc /Adv holds 42,994 shares of DXCM stock, worth $2.95 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
42,994
Previous 44,986 4.43%
Holding current value
$2.95 Million
Previous $5.1 Billion 43.49%
% of portfolio
0.32%
Previous 0.6%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$64.0 - $116.06 $127,488 - $231,191
-1,992 Reduced 4.43%
42,994 $2.88 Billion
Q2 2024

Jul 30, 2024

BUY
$110.31 - $140.45 $220 - $280
2 Added 0.0%
44,986 $5.1 Billion
Q1 2024

Apr 19, 2024

SELL
$114.22 - $140.1 $342 - $420
-3 Reduced 0.01%
44,984 $6.24 Billion
Q4 2023

Apr 01, 2024

BUY
$75.49 - $124.16 $1,887 - $3,104
25 Added 0.06%
44,987 $5.58 Billion
Q3 2023

Apr 01, 2024

BUY
$86.06 - $137.93 $1,721 - $2,758
20 Added 0.04%
44,962 $4.19 Billion
Q2 2023

Apr 01, 2024

SELL
$112.47 - $130.98 $506,002 - $589,279
-4,499 Reduced 9.1%
44,942 $5.78 Billion
Q1 2023

Apr 01, 2024

BUY
$104.0 - $122.92 $3.28 Million - $3.88 Million
31,551 Added 176.36%
49,441 $5.74 Billion
Q4 2022

Apr 01, 2024

SELL
$84.98 - $122.67 $560,103 - $808,517
-6,591 Reduced 26.92%
17,890 $2.03 Billion
Q3 2022

Apr 01, 2024

SELL
$76.35 - $94.18 $152 - $188
-2 Reduced 0.01%
24,481 $4.23 Billion
Q2 2022

Apr 01, 2024

BUY
$67.99 - $132.89 $929,491 - $1.82 Million
13,671 Added 126.44%
24,483 $4.13 Billion
Q1 2022

Apr 01, 2024

BUY
$94.08 - $130.2 $109,415 - $151,422
1,163 Added 12.05%
10,812 $5.53 Billion
Q4 2021

Apr 01, 2024

SELL
$129.87 - $162.82 $1,168 - $1,465
-9 Reduced 0.09%
9,649 $5.18 Billion
Q1 2021

Apr 01, 2024

BUY
$84.79 - $104.74 $66,475 - $82,116
784 Added 8.83%
9,658 $3.47 Billion
Q4 2020

Apr 01, 2024

BUY
$78.0 - $104.5 $79,326 - $106,276
1,017 Added 12.94%
8,874 $3.28 Billion
Q3 2020

Apr 01, 2024

BUY
$95.51 - $112.95 $85,385 - $100,977
894 Added 12.84%
7,857 $3.24 Billion
Q2 2020

Apr 01, 2024

BUY
$62.68 - $105.34 $41,744 - $70,156
666 Added 10.58%
6,963 $2.82 Billion
Q1 2020

Apr 01, 2024

SELL
$47.79 - $75.63 $317,755 - $502,863
-6,649 Reduced 51.36%
6,297 $1.7 Billion
Q3 2019

Apr 01, 2024

BUY
$35.53 - $43.8 $166,067 - $204,721
4,674 Added 56.5%
12,946 $3.72 Billion
Q1 2019

Apr 01, 2024

BUY
$28.07 - $38.18 $7,073 - $9,621
252 Added 3.14%
8,272 $985 Million
Q4 2018

Apr 01, 2024

BUY
$26.99 - $37.37 $39,243 - $54,335
1,454 Added 22.14%
8,020 $961 Million
Q3 2018

Apr 01, 2024

BUY
$23.35 - $36.72 $15,784 - $24,822
676 Added 11.48%
6,566 $939 Million
Q2 2018

Apr 01, 2024

BUY
$17.54 - $25.22 $103,310 - $148,545
5,890 New
5,890 $559 Million
Q2 2017

Apr 03, 2024

SELL
N/A
-39,097
5,890 $431 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Azzad Asset Management Inc /Adv Portfolio

Follow Azzad Asset Management Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.